Cell And Gene Therapy Manufacturing Market Size, Share & Trends Report

Cell And Gene Therapy Manufacturing Market Size, Share & Trends Analysis Report By Therapy Type, By Scale (R&D, Commercial), By Mode, By Workflow (Vector Production, Cell Banking), By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Jul, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68038-289-1
  • Format: Electronic (PDF)
  • Historical Data: 2017 - 2019
  • Number of Pages: 188

Table of Content

Chapter 1 Methodology And Scope
                   1.1 Research Methodology
                   1.2 Research Assumptions
                       1.2.1 Estimates And Forecast Timeline
                   1.3 Research Methodology
                   1.4 Information Procurement
                       1.4.1 Purchased Database
                       1.4.2 Gvr’s Internal Database
                       1.4.3 Secondary Sources
                       1.4.4 Primary Research
                       1.4.5 Details Of Primary Research
                   1.5 Information Or Data Analysis
                       1.5.1 Data Analysis Models
                   1.6 Market Formulation & Validation
                   1.7 Model Details
                       1.7.1 Commodity Flow Analysis
                   1.8 Market: Cagr Calculation
                   1.9 List Of Secondary Sources
                   1.10 Objectives
                       1.10.1 Objective 1:
                       1.10.2 Objective 2:
Chapter 2 Executive Summary
                   2.1 Competition Milieu
                   2.2 Segment Outlook
                   2.3 Market Summary, 2020 (USD Million)
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Segmentation
                   3.2 Parent Market Lineage
                   3.3 Ancillary Market Lineage
                   3.4 Market Dynamics
                       3.4.1 Market Drivers Analysis
                           3.4.1.1 Growing Pipeline Of Cell And Gene Therapy
                           3.4.1.2 Supportive Regulatory Bodies
                           3.4.1.3 Increase In Investment By Government And Private Players
                       3.4.2 Market Restraint Analysis
                           3.4.2.1 Technological Challenges Associated With Manufacturing
                           3.4.2.2 High Cost Of Manufacturing
                       3.4.3 Market Opportunity Analysis
                           3.4.3.1 Rising Pressure On Drug Developers/Manufacturers To Meet The Growing Market Demand
                           3.4.3.2 Expansion In Potential Markets Such As Asia Pacific And Latin America
                       3.4.4 Market Challenge Analysis
                           3.4.4.1 Lack Of Manufacturing Capacity
                   3.5 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
                   3.6 Porter’s Five Forces Analysis
                   3.7 Major Deals And Strategic Alliances Analysis
                       3.7.1 Mergers And Acquisitions
                       3.7.2 Technological Collaborations
                       3.7.3 Licensing And Partnerships
                   3.8 Covid-19 Impact Analysis
                       3.8.1 Challenge Analysis
                       3.8.2 Opportunity Analysis
                       3.8.3 Key Developments And Activities
Chapter 4 Competitive Analysis
                   4.1 Recent Developments And Impact Analysis By Key Market Participants
                   4.2 Company Mapping, By Location, Purpose, Scale Of Operation, Source Of Cell, Regulatory Compliant
                   4.3 List Of Potential End Users
                   4.4 List Of Emerging Players
                   4.5 Market Differentiators
                   4.6 Competitive Dashboard Analysis
                   4.7 Regional Network Map
Chapter 5 Therapy Type Business Analysis
                   5.1 Cell And Gene Therapy Manufacturing Market: Therapy Type Movement Analysis
                   5.2 Cell Therapy Manufacturing
                       5.2.1 Cell Therapy Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)
                       5.2.2 Stem Cell Therapy
                           5.2.2.1 Cell Therapy Manufacturing Market Estimates And Forecast For Stem Cell Therapy, 2017 - 2028 (USD Million)
                       5.2.3 Non-Stem Cell Therapy
                           5.2.3.1 Cell Therapy Manufacturing Market Estimates And Forecast For Non-Stem Cell Therapy, 2017 - 2028 (USD Million)
                   5.3 Gene Therapy Manufacturing
                       5.3.1 Gene Therapy Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)
Chapter 6 Scale Business Analysis
                   6.1 Cell And Gene Therapy Manufacturing Market: Scale Movement Analysis
                   6.2 Pre-Commercial/R&D Scale Manufacturing
                       6.2.1 Cell And Gene Therapy Manufacturing market Estimates And Forecast For Pre-Commercial/R&D Scale Manufacturing, 2017 - 2028 (USD Million)
                   6.3 Commercial Scale Manufacturing
                       6.3.1 Cell And Gene Therapy Manufacturing market Estimates And Forecast For Commercial Scale Manufacturing, 2017 - 2028 (USD Million)
Chapter 7 Mode Business Analysis
                   7.1 Cell And Gene Therapy Manufacturing Market: Mode Movement Analysis
                   7.2 Contract Manufacturing
                       7.2.1 Cell And Gene Therapy Manufacturing market For Contract Manufacturing, 2017 - 2028 (USD Million)
                   7.3 In-House Manufacturing
                       7.3.1 Cell And Gene Therapy Manufacturing market For In-House Manufacturing, 2017 - 2028 (USD Million)
Chapter 8 Workflow Business Analysis
                   8.1 Cell And Gene Therapy Manufacturing Market: Workflow Movement Analysis
                   8.2 Cell Processing
                       8.2.1 Cell And Gene Therapy Manufacturing Market For Cell Processing, 2017 - 2028 (USD Million)
                   8.3 Cell Banking
                       8.3.1 Cell And Gene Therapy Manufacturing Market For Cell Banking, 2017 - 2028 (USD Million)
                   8.4 Process Development
                       8.4.1 Cell And Gene Therapy Manufacturing Market For Process Development, 2017 - 2028 (USD Million)
                   8.5 Fill And Finish Operations
                       8.5.1 Cell And Gene Therapy Manufacturing Market For Fill And Finish Operations, 2017 - 2028 (USD Million)
                   8.6 Analytical And Quality Testing
                       8.6.1 Cell And Gene Therapy Manufacturing Market For Analytical And Quality Testing, 2017 - 2028 (USD Million)
                   8.7 Raw Material Testing
                       8.7.1 Cell And Gene Therapy Manufacturing Market For Raw Material Testing, 2017 - 2028 (USD Million)
                   8.8 Vector Production
                       8.8.1 Cell And Gene Therapy Manufacturing Market For Vector Production, 2017 - 2028 (USD Million)
                   8.9 Others
                       8.9.1 Cell And Gene Therapy Manufacturing Market For Other Workflows, 2017 - 2028 (USD Million)
Chapter 9 Regional Business Analysis
                   9.1 Cell And Gene Therapy Manufacturing Market: Regional Movement Analysis
                   9.2 North America
                       9.2.1 North America Cell And Gene Therapy Manufacturing Market Estimates And Forecast,2017 - 2028 (USD Million)
                       9.2.2 U.S.
                           9.2.2.1 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.2.2.2 U.S. Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.2.2.3 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.2.2.4 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.2.2.5 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.2.3 Canada
                           9.2.3.1 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.2.3.2 Canada Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.2.3.3 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.2.3.4 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.2.3.5 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                   9.3 Europe
                       9.3.1 Europe Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
                       9.3.2 Germany
                           9.3.2.1 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.3.2.2 Germany Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.3.2.3 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.3.2.4 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.3.2.5 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.3.3 U.K.
                           9.3.3.1 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.3.3.2 U.K. Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.3.3.3 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.3.3.4 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.3.3.5 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.3.4 France
                           9.3.4.1 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.3.4.2 France Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.3.4.3 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.3.4.4 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.3.4.5 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.3.5 Italy
                           9.3.5.1 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.3.5.2 Italy Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.3.5.3 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.3.5.4 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.3.5.5 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.3.6 Spain
                           9.3.6.1 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.3.6.2 Spain Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.3.6.3 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.3.6.4 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.3.6.5 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                   9.4 Asia Pacific
                       9.4.1 Asia Pacific Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
                       9.4.2 Japan
                           9.4.2.1 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.4.2.2 Japan Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.4.2.3 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.4.2.4 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.4.2.5 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.4.3 China
                           9.4.3.1 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.4.3.2 China Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.4.3.3 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.4.3.4 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.4.3.5 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.4.4 India
                           9.4.4.1 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.4.4.2 India Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.4.4.3 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.4.4.4 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.4.4.5 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.4.5 South Korea
                           9.4.5.1 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.4.5.2 South Korea Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.4.5.3 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.4.5.4 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.4.5.5 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                   9.5 Latin America
                       9.5.1 Latin America Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
                       9.5.2 Brazil
                           9.5.2.1 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.5.2.2 Brazil Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.5.2.3 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.5.2.4 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.5.2.5 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.5.3 Mexico
                           9.5.3.1 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.5.3.2 Mexico Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.5.3.3 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.5.3.4 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.5.3.5 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                   9.6 Middle East & Africa
                       9.6.1 Middle East & Africa Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
                       9.6.2 South Africa
                           9.6.2.1 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.6.2.2 South Africa Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.6.2.3 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.6.2.4 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.6.2.5 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
                       9.6.3 Saudi Arabia
                           9.6.3.1 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
                           9.6.3.2 Saudi Arabia Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
                           9.6.3.3 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
                           9.6.3.4 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
                           9.6.3.5 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
Chapter 10 Company Profiles
                   10.1 Strategy Framework
                   10.2 Market Participation Categorization
                   10.3 Company Profiles
                       10.3.1 Thermofisher Scientific
                           10.3.1.1 Company Overview
                           10.3.1.2 Financial Performance
                           10.3.1.3 Product Benchmarking
                           10.3.1.4 strategic Initiatives
                       10.3.2 MERCK KGAA.
                           10.3.2.1 Company Overview
                           10.3.2.2 Milliporesigma
                           10.3.2.3 Financial Performance
                           10.3.2.4 Product Benchmarking
                           10.3.2.5 Strategic Initiatives
                       10.3.3 LONZA
                           10.3.3.1 Company Overview
                           10.3.3.2 Financial Performace
                           10.3.3.3 Product Benchmarking
                           10.3.3.4 Strategic Initiatives
                       10.3.4 CATALENT INC.
                           10.3.4.1 Company Overview
                           10.3.4.2 Financial Performance
                           10.3.4.3 Product Benchmarking
                           10.3.4.4 Strategic Initiatives
                       10.3.5 TAKARA BIO INC.
                           10.3.5.1 Company Overview
                           10.3.5.2 Financial Performance
                           10.3.5.3 Product Benchmarking
                           10.3.5.4 Strategic Initiatives
                       10.3.6 F.HOFFMANN-LA ROCHE LTD
                           10.3.6.1 Company Overview
                           10.3.6.2 Financial Performance
                           10.3.6.3 Product Benchmarking
                           10.3.6.4 Strategic Initiatives
                       10.3.7 WUXI ADVANCED THERAPIES
                           10.3.7.1 Company Overview
                           10.3.7.2 Financial Performance
                           10.3.7.3 Product Benchmarking
                           10.3.7.4 Strategic Initiatives
                       10.3.8 SAMSUNG BIOLOGICS
                           10.3.8.1 Company Overview
                           10.3.8.2 Financial Performance
                           10.3.8.3 Product Benchmarking
                           10.3.8.4 Strategic Initiatives
                       10.3.9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
                           10.3.9.1 Company Overview
                           10.3.9.2 Financial Performance
                           10.3.9.3 Product Benchmarking
                           10.3.9.4 Strategic Initiatives
                       10.3.10 NOVARTIS AG
                           10.3.10.1 Company Overview
                           10.3.10.2 Financial Performance
                           10.3.10.3 Product Benchmarking
                           10.3.10.4 Strategic Initiatives
                       10.3.11 HITACHI CHEMICAL CO LTD.
                           10.3.11.1 Company Overview
                           10.3.11.2 Apceth Biopharma
                           10.3.11.3 Financial Performance
                           10.3.11.4 Product Benchmarking
                           10.3.11.5 Strategic Initiatives
                       10.3.12 CELLULAR THERAPEUTICS.
                           10.3.12.1 Company Overview
                           10.3.12.2 Financial Performance
                           10.3.12.3 Product Benchmarking
                       10.3.13 MILTENYI BIOTECH.
                           10.3.13.1 Company Overview
                           10.3.13.2 Financial Performance
                           10.3.13.3 Product Benchmarking
                           10.3.13. 4strategic Initiatives
                       10.3.14 BLUEBIRD BIO INC.
                           10.3.14.1 Company Overview
                           10.3.14.2 Financial Performance
                           10.3.14.3 Product Benchmarking
                           10.3.14.4 Strategic Initiatives


List of Tables

Table 1 List of secondary sources
Table 2 CMO Investments in API Biologics - Cell, Gene, Vaccine, and Virus, April-July 2020
Table 3 FDA approved Cellular and Gene Therapy Products as of July 2020
Table 4 Cell and Gene Therapy Products approved in the European Union
Table 5 Summary of risk factors associated with COVID-19 transmission in cell and gene therapy manufacturing
Table 6 Impact Analysis
Table 7 List of cell therapy manufacturers:
Table 8 List of potential end-users
Table 9 List of emerging players
Table 10 List of market differentiators
Table 11 Competitive dashboard analysis
Table 12 Regional network map
Table 13 Top cell therapy companies of 2020
Table 14 Testing methods
Table 15 Best Practices for the effective control of raw material
Table 16 Operating CMOs/ CDMOs for cell and gene therapy manufacturing in North America
Table 17 Cell and Gene Therapy Manufacturing Capacity in North America as of 2018
Table 18 Operating CMOs/ CDMOs for cell and gene therapy manufacturing in the EU
Table 19 Cell & Gene Therapy Manufacturing Capacities in Europe 2017
Table 20 Distribution of cleanroom footprint, and QC footprint across the U.K.
Table 21 Aggregated total number of cellular therapy product manufacturing facilities, GMP laboratories, manufacturing and quality staff, parallel processes, and projects by country and state/region.
Table 22 Noteworthy regenerative medicine CMOs in operation in Japan
Table 23 North America cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 24 North America cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 25 North America cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 26 North America cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 27 North America cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 28 U.S. cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 29 U.S. cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 30 U.S. cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 31 U.S. cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 32 U.S. cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 33 Canada cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 34 Canada cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 35 Canada cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 36 Canada cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 37 Canada cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 38 Europe cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 39 Europe cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 40 Europe cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 41 Europe cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 42 Europe cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 43 Germany cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 44 Germany cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 45 Germany cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 46 Germany cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 47 Germany cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 48 U.K. cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 49 U.K. cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 50 U.K. cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 51 U.K. cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 52 U.K. cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 53 Italy cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 54 Italy cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 55 Italy cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 56 Italy cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 57 Italy cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 58 France cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 59 France cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 60 France cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 61 France cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 62 France cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 63 Spain cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 64 Spain cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 65 Spain cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 66 Spain cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 67 Spain cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 68 Asia Pacific cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 69 Asia Pacific cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 70 Asia Pacific cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 71 Asia Pacific cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 72 Asia Pacific cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 73 Japan cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 74 Japan cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 75 Japan cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 76 Japan cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 77 Japan cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 78 China cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 79 China cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 80 China cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 81 China cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 82 China cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 83 India cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 84 India cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 85 India cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 86 India cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 87 India cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 88 South Korea cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 89 South Korea cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 90 South Korea cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 91 South Korea cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 92 South Korea cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 93 Latin America cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 94 Latin America cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 95 Latin America cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 96 Latin America cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 97 Latin America cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 98 Brazil cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 99 Brazil cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 100 Brazil cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 101 Brazil cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 102 Brazil cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 103 Mexico cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 104 Mexico cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 105 Mexico cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 106 Mexico cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 107 Mexico cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 108 MEA cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 109 MEA cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 110 MEA cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 111 MEA cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 112 MEA cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 113 South Africa cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 114 South Africa cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 115 South Africa cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 116 South Africa cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 117 South Africa cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
Table 118 Saudi Arabia cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
Table 119 Saudi Arabia cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
Table 120 Saudi Arabia cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
Table 121 Saudi Arabia cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
Table 122 Saudi Arabia cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Medicines in development by disease
Fig. 9 Classification of companies
Fig. 10 Cell and gene therapy manufacturing market snapshot, 2020 (USD Million)
Fig. 11 Cell &gene therapy manufacturing market segmentation
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Gene therapy clinical trials number as of 2019
Fig. 14 Regenerative medicine clinical trials
Fig. 15 Expedited approval pathway designations by technology
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Market opportunity relevance analysis (Current & future impact)
Fig. 18 Cell and gene therapy market SWOT analysis
Fig. 19 Cell and gene therapy market Porter’s five forces analysis
Fig. 20 Cell therapy manufacturing collaborations from 2014 to 2018
Fig. 21 Areas of disruption due to COVID-19 reported by respondents
Fig. 22 Cell and gene therapy market: Therapy type outlook and key takeaways
Fig. 23 Cell and gene therapy market: Therapy type movement analysis
Fig. 24 Cell therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 25 Cell therapy manufacturing market estimates and forecast for stem cell therapy, 2017 - 2028 (USD Million)
Fig. 26 Cell therapy manufacturing market estimates and forecast for non-stem cell therapy, 2017 - 2028 (USD Million)
Fig. 27 Gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 28 Cell and gene therapy Manufacturing market: Scale outlook and key takeaways
Fig. 29 Cell and gene therapy Manufacturing market: Scale movement analysis
Fig. 30 Cell and gene therapy manufacturing market estimates and forecast for pre-commercial scale manufacturing, 2017 - 2028 (USD Million)
Fig. 31 Cell and gene therapy Manufacturing) market estimates and forecast for commercial scale manufacturing, 2017 - 2028 (USD Million)
Fig. 32 Cell and gene therapy manufacturing market: Mode outlook and key takeaways
Fig. 33 Cell and gene therapy manufacturing market: Mode movement analysis
Fig. 34 Cell and gene therapy manufacturing market for contract manufacturing, 2017 - 2028 (USD Million)
Fig. 35 Cell and gene therapy manufacturing market for in-house manufacturing, 2017 - 2028 (USD Million)
Fig. 36 Cell and gene therapy manufacturing market: Workflow outlook and key takeaways
Fig. 37 Cell and gene therapy manufacturing market: Workflow movement analysis
Fig. 38 Cell and gene therapy manufacturing market for cell processing, 2017 - 2028 (USD Million)
Fig. 39 Cell and gene therapy manufacturing market for cell banking, 2017 - 2028 (USD Million)
Fig. 40 Cell and gene therapy manufacturing market for process development, 2017 - 2028 (USD Million)
Fig. 41 Cell and gene therapy manufacturing market for fill and finish operations, 2017 - 2028 (USD Million)
Fig. 42 Cell and gene therapy manufacturing market for analytical and quality testing, 2017 - 2028 (USD Million)
Fig. 43 Cell and gene therapy manufacturing market for raw material testing, 2017 - 2028 (USD Million)
Fig. 44 Cell and gene therapy manufacturing market for vector production, 2017 - 2028 (USD Million)
Fig. 45 Cell and gene therapy manufacturing market for others, 2017 - 2028 (USD Million)
Fig. 46 Cell and gene therapy manufacturing market: Regional outlook and key takeaways
Fig. 47 Cell and Gene therapy manufacturing market: Regional movement analysis
Fig. 48 North America cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 49 U.S. cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 50 Canada cell and gene therapy manufacturing) market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 51 Europe cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 52 Germany cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 53 U.K. cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 54 France cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 55 Italy cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 56 Spain cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 57 Asia Pacific cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 58 Japan cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 59 China cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 60 India cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 61 South Korea cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 62 Latin America cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 63 Brazil cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 64 Mexico cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 65 Middle East & Africa cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 66 South Africa cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 67 Saudi Arabia cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 68 Strategy framework
Fig. 69 Market participation categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.